Obchodní jednání

our partners

We nurture our partnerships, because we treat every single partner as a part of our family. We are grateful of their trust, their know-how is an inspiration to us.

logo i&i Prague výška2.png

i&i Prague

Biotech Incubator

We were born from i&i Prague. This biotech incubator specializes in the transfer of new technologies into practice. It was established as a subsidiary of the Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, and primarily focuses on innovations in the areas of drug discovery, diagnostics, and medical devices developed by academic institutions. It supports the creation of spin-offs and the sale of licenses.

Support of i&i Prague:

  • sourcing deals through i&i Prague’s own relationships with regional R&D organizations

  • identification of projects with great commercial potential (namely in the space of public R&D organizations – a space not easily accessible to existing private investors)

  • evaluation of projects (access to top-notch expertise within i&i and the whole IOCB structure)

  • assistance with business setup (turning non-investable scientific projects into investable companies with a dedicated and incentivized project team and strong corporate governance)

  • potential to invest in projects incubated by i&i Prague, with clear rules basically covering only incubation costs of i&i without any profit


The European Investment Fund

i&i Biotech fund is supported by an investment from the EIF, with the support of:

  • lnnovFin Equity, with the financial backing of the European Union under Horizon 2020 Financial Instruments and the European Fund for Strategic Investments (EFSI) set up under the Investment Plan for Europe. The purpose of EFSI is to help support financing and implementing productive investments in the European Union and to ensure increased access to financing; and

  • the Pan-European Guarantee Fund (EGF), implemented by the EIF with the financial support of the Participating Member States. The objective of EGF is to respond to the economic impact of the COVID-19 pandemic by ensuring that companies in the Participating Member States have sufficient short-term liquidity available to weather the crisis and are able to continue their growth and development in the medium to long-term.

eif web.png
icob tech web.png


Technology Transfer Office

IOCBTech is a technology transfer office and subsidiary company of IOCB (the Institute of Organic Chemistry and Biochemistry CAS). The company matches results of basic research done at the IOCB with needs of commercial partners to ultimately bring new ideas in medicinal chemistry, material sciences, and other fields of chemistry to human use.

Institute of Organic Chemistry and Biochemistry of the CAS

Leading Czech Research Institution

IOCB Prague is a leading research institution under the umbrella of the Czech Academy of Sciences. Their mission is basic research at the interface of chemical and biological sciences, and translation of results from basic research into applications and commercial assets.

uochb tech web.png
cuip web.png

Charles University Innovations Prague

Subsidiary of Charles University

Charles University Innovations Prague a.s. (CUIP) is a subsidiary of Charles University, which was founded on 22nd June 2018. Its goal is to encourage and facilitate transfer of knowledge and technology from academic research into daily life.


Czech Academy of Sciences

The primary mission of the CAS and its institutes is to conduct research in a broad spectrum of the natural, technical and social sciences and the humanities. This research aims to advance developments in scientific knowledge at the international level, while also taking into account the specific needs of both Czech society and national culture. 

av1 web.png